Shots:

• The companies will collaborate on drug commercialization initiatives in China- including the commercialization of innovative drugs & healthcare products for chronic disease management- as well as providing reliable and convenient resources for patient education
• Bayer will leverage 111's vast network of pharmacies and healthcare providers to enhance its channel management and patient outreach capabilities- as well as to increase its market presence in several underserved markets in China's tier 3-6 cities
• The companies will jointly develop a digitalized content portal that will provide online pharmacist training and interactive patient education content and services

 ­ Ref: PRNewswire | Image: Silver Peak Blog